Advertisement

Topics

Shares in Lupin lose 18% following US FDA warning

09:24 EST 8 Nov 2017 | thePharmaLetter

Indian pharma major Lupin has suffered a major drop in share price after the US FDA issued the firm with…

Original Article: Shares in Lupin lose 18% following US FDA warning

NEXT ARTICLE

More From BioPortfolio on "Shares in Lupin lose 18% following US FDA warning"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...